Eagle Pharmaceuticals (EGRX)
$43.53 1.61 (3.57%)
17:01 EDT EGRX Stock Quote Delayed 20 Minutes
Previous Close $43.53
Market Cap 645.79M
PE Ratio 21.55
Volume (Avg. Vol.) 87,700
Day's Range 42.63 - 45.25
52-Week Range 33.80 - 64.94
Dividend & Yield N/A (N/A)
EGRX Stock Predictions, Articles, and Eagle Pharmaceuticals News
- From InvestorPlace
- From the Web
An Obamacare replacement is back in the news, and these seven A-rated healthcare stocks are winners regardless of how it shakes out.
The second quarter is about making money without worrying about Washington or Wall Street. These seven are the "best of the best" stocks to buy for Q2.
The world was shocked by Donald Trump's surprise victory, but few equities will benefit as much as big pharma stocks.
This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Why Cypress Semiconductor Corporation (CY), Eagle Pharmaceuticals Inc (EGRX) and Energy Transfer Equity LP (ETE) Are 3 of Today’s Worst Stocks
Cypress Semiconductor (CY), Eagle Pharmaceuticals (EGRX) and Energy Transfer Equity (ETE) were left out of Monday's mostly market-wide rally.
The ratings of 27 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
If you're a fan of growth stocks and healthcare stocks ... well, these seven names would've done you well in 2015. A few of them could keep soaring.
From Simply Wall St
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-egrx/eagle-pharmaceuticals/news/read-this-before-judging-eagle-pharmaceuticals-inc-s-nasdaqegrx-roe/">Read More...</a></div>
From Analyst Ratings
RBC Capital analyst Randall Stanicky maintained a Buy rating on Eagle Pharmaceuticals (EGRX – Research Report) today and set a price target of $59.00. The company’s shares closed last Monday at $40.94. According to TipRanks.com, Stanicky is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -21.5% and
From Market News Video
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in American Airlines Group Inc (AAL), where a total of 237,681 contracts have traded so far, representing approximately 23.8 million underlying shares. That amounts to about 61.1% of AAL's average daily trading volume over the past month of 38.9 million shares..
The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index
Navellier RatingsPowered by Portfolio Grader